wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41362230-532D204F-2028-41BF-A993-C837E01B1893
Q41362230-532D204F-2028-41BF-A993-C837E01B1893
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41362230-532D204F-2028-41BF-A993-C837E01B1893
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
P2860
Q41362230-532D204F-2028-41BF-A993-C837E01B1893
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41362230-532D204F-2028-41BF-A993-C837E01B1893
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
952c69402b618acc655e137ab6063b83e5032e4f
P2860
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.